Table 1.
Patient characteristics (n = 47)a
| N = 47 (100%) | |
|---|---|
| Age (median, range) | 58 (34–77) |
| FIGO stage | |
| II | 1 (2.1) |
| IIIA | 1 (2.1) |
| IIIB | 5 (10.6) |
| IIIC | 32 (68.2) |
| IV | 8 (17.0) |
| Residual disease | |
| None | 16 (34.0) |
| < 2 cm | 17 (36.2) |
| > 2 cm | 13 (27.7) |
| Numbers of chemotherapy cycles | |
| < 6 | 7 (14.9) |
| 6 or more | 39 (83.0) |
| CSb | 33 (70.2) |
| CRb | 14 (29.8) |
| 6-month RFS % (95%CI)c | 0.53 (0.38–0.66) |
| 3-year OS % (95%CI)c | 0.47 (0.29–0.63) |
amissing clinicopathological information was assumed to be missing at random
bCS chemosensitive, CR chemoresistant
cRFS recurrence-free survival, OS overall survival